An at-the-market program has been established by Chembio Diagnostics through which it may occasionally offer up to $21.2 million worth of its common stock. The company plans to use net proceeds from the program as working capital, as well as for investments in business operations and possible acquisitions.
At-the-market program for stock offering announced by Chembio
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.